MEG3 and renal cell carcinoma: MEG3 has been shown to be methylated in human renal cell carcinoma tissues and cell lines, as well as in pheochromocytomas and human pituitary tumors[34–36], and promoter hypermethylation downregulated MEG3 expression and promotes oncogenesis[36].